Related Experiment Video
Updated: Jun 10, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
In vitro tests with sensitized lymphocytes-Relevance for predictive allergenicity testing
B M von Blomberg-van der Flier1, R J Scheper
1Department of Pathology, Free University Hospital, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Summary
Identifying contact sensitizers requires improved in vitro methods. The local lymph node assay shows promise for allergenicity testing by combining in vivo allergen presentation with in vitro lymphocyte activation assessment.
Area of Science:
- Immunotoxicology
- Dermatology
- Allergenicity Testing
Background:
- In vitro methods for identifying contact sensitizers face challenges due to improper allergen application.
- Allergen solubility, toxicity, and the need for skin tissue conjugation limit current in vitro approaches.
Purpose of the Study:
- To evaluate promising methods for allergenicity testing that overcome limitations of traditional in vitro assays.
- To highlight the potential of assays combining in vivo and in vitro components for predictive allergenicity screening.
Main Methods:
- Investigating methods that utilize in vivo systems for allergen binding and presentation.
- Assessing subsequent lymphocyte activation in vitro following in vivo allergen exposure.
- Considering the local lymph node assay (LLNA) as a predictive tool.
Main Results:
- Methods combining in vivo allergen presentation with in vitro lymphocyte assessment are most promising.
- The local lymph node assay warrants further validation and attention in allergenicity testing.
- Standard in vitro allergen-stimulated tests have limited value for predictive screening but are useful for mechanistic studies.
Conclusions:
- The local lymph node assay is a promising predictive assay for allergenicity testing that requires further validation.
- While limited for screening, in vitro tests are valuable for understanding contact sensitivity mechanisms.
- Lymphocyte transformation and macrophage migration inhibition tests can aid clinical diagnosis when skin tests are inconclusive.

